mRNA-based vaccines for the prevention of coronavirus infection
Since March 2020, the World Health Organization has declared a coronavirus infection pandemic. Almost immediately, the development of vaccines began, according to the recommendations published by WHO. Currently, 137 vaccines in the world are undergoing clinical trials and 194 are at the stage of pre...
Saved in:
| Main Authors: | S. M. Kharit, I. V. Fridman |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Journal Infectology
2022-04-01
|
| Series: | Журнал инфектологии |
| Subjects: | |
| Online Access: | https://journal.niidi.ru/jofin/article/view/1303 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of vector vaccines for the prevention of new coronavirus infection
by: S. M. Kharit, et al.
Published: (2022-07-01) -
Do repeated vaccinations affect the incidence of coronavirus infection?
by: K. K. Tikhomirova, et al.
Published: (2025-06-01) -
Development of mRNA rabies vaccines
by: Zixin Fang, et al.
Published: (2024-12-01) -
The effectiveness of vaccination and booster vaccinations against new coronavirus infection in real practice
by: K. K. Tikhomirova, et al.
Published: (2024-09-01) -
The mRNA-1647 vaccine: A promising step toward the prevention of cytomegalovirus infection (CMV)
by: Adewunmi Akingbola, et al.
Published: (2025-12-01)